When did Citius Oncology, Inc. report Q1 2025 earnings?

Citius Oncology, Inc. (CTOR) reported Q1 2025 earnings on May 14, 2025 before market open.

What were Citius Oncology, Inc.'s Q1 2025 revenue and EPS?

Citius Oncology, Inc. reported diluted EPS of $-0.11 for Q1 2025.

Did Citius Oncology, Inc. beat estimates in Q1 2025?

EPS missed the consensus estimate of $-0.09 by $0.02.

Where can I find Citius Oncology, Inc.'s Q1 2025 SEC filings?

You can read the 10-K/A periodic report (0001213900-25-007012) directly on SEC EDGAR. The filing index links above go to sec.gov.

Citius Oncology, Inc. CTOR Q1 2025 Annual earnings

Reported May 14, 2025 · Before market open

Diluted EPS-$0.11Miss by $0.02

Revenue estimate$5.7M

EPS estimate-$0.09

Next report

Aug 18, 2026 (in a month)

Revenue estimate$5.8M

EPS estimate-$0.04

Financials

Q1 2025

Income statement

See full

Operating income-$6.4M+29.0%

Net income-$6.7M-40.9%

EPS (diluted)-$0.09-28.6%

Balance sheet

See full

Cash & equivalents$112.0-99.7%

Total equity$41.3M+81.7%

Total assets$90.5M+24.6%

Cash flow

See full

Operating cash flow-$1.4M-4,447%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$82.29M—

Returns & leverage

See full

Return on equity-72.1%-219pp

Current ratio0.4×+0.4×

Versus estimates

Revenue

Q2 2026$1.7MMiss by $5.3M Q1 2026$3.9MMiss by $428.9K

Diluted EPS

Q2 2026-$0.27Miss by $0.26 Q1 2026-$0.06Miss by $0.02 Q4 2025-$0.06In line Q3 2025-$0.08Beat by $0.07

Q1 2025-$0.11Miss by $0.02

Q4 2024-$0.09Miss by $0.03

Ask the moment Citius Oncology, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Citius Oncology, Inc. report Q1 2025 earnings?: Citius Oncology, Inc. (CTOR) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Citius Oncology, Inc.'s Q1 2025 revenue and EPS?: Citius Oncology, Inc. reported diluted EPS of $-0.11 for Q1 2025.
Did Citius Oncology, Inc. beat estimates in Q1 2025?: EPS missed the consensus estimate of $-0.09 by $0.02.
Where can I find Citius Oncology, Inc.'s Q1 2025 SEC filings?: You can read the 10-K/A periodic report (0001213900-25-007012) directly on SEC EDGAR. The filing index links above go to sec.gov.